Predicting Response to Intravesical Bacillus Calmette-Guérin in High-Risk Nonmuscle-Invasive Bladder Cancer Using an Artificial Intelligence–Powered Pathology Assay: Development and Validation in an International 12-Center Cohort
This article is commented on by the following:
- Yair Lotan,
- Viswesh Krishna,
- Waleed M. Abuzeid,
- Bryn Launer,
- Sam S. Chang,
- Vrishab Krishna,
- Siddhant Shingi,
- Jennifer B. Gordetsky,
- Thomas Gerald,
- Solomon Woldu,
- Eugene Shkolyar,
- Dickon Hayne,
- Andrew Redfern,
- Lisa Spalding,
- Courtney Stewart,
- Eduardo Eyzaguirre,
- Shamsunnahar Imtiaz,
- Vikram M. Narayan,
- Vignesh T. Packiam,
- Michael A. O’Donnell,
- Roger Li,
- Loic Baekelandt,
- Steven Joniau,
- Tahlita Zuiverloon,
- Mario I. Fernandez,
- Marcela Schultz,
- Patrick J. Hensley,
- Derek Allison,
- John A. Taylor,
- Ameer Hamza,
- Ashish Kamat,
- Vivek Nimgaonkar,
- Snehal Sonawane,
- Daniel L. Miller,
- Drew Watson,
- Damir Vrabac,
- Anirudh Joshi,
- Jay B. Shah, and
- Stephen B. Williams
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas
Valar Labs, Palo Alto, California
https://orcid.org/0000-0003-2489-0514
Valar Labs, Palo Alto, California
Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee
Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee
Valar Labs, Palo Alto, California
Valar Labs, Palo Alto, California
Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas
Department of Urology, Stanford Medicine, Palo Alto, California
Department of Urology, University of Western Australia, Perth, Australia
Department of Medical Oncology, University of Western Australia, Perth, Australia
Department of Urology, University of Western Australia, Perth, Australia
Department of Urology, University of Texas Medical Branch, Galveston, Texas
Department of Pathology, University of Texas Medical Branch, Galveston, Texas
Department of Urology, Emory University School of Medicine, Atlanta, Georgia
Department of Urology, Emory University School of Medicine, Atlanta, Georgia
Department of Urology, University of Iowa, Iowa City, Iowa
Department of Urology, University of Iowa, Iowa City, Iowa
Department of Urology, Moffitt Cancer Center, Tampa, Florida
Department of Urology, UZ Leuven, Leuven, Belgium
Department of Urology, UZ Leuven, Leuven, Belgium
Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands
Department of Urology, Clínica Alemana Universidad del Desarrollo, Santiago, Chile
Department of Pathology, Clínica Alemana Universidad del Desarrollo, Santiago, Chile
Department of Urology, University of Kentucky College of Medicine, Lexington, Kentucky
Department of Pathology, University of Kentucky College of Medicine, Lexington, Kentucky
Department of Urology, University of Kansas Medical Center, Kansas City, Kansas
Department of Pathology, University of Kansas Medical Center, Kansas City, Kansas
Department of Urology, MD Anderson Cancer Center, Houston, Texas
Valar Labs, Palo Alto, California
Valar Labs, Palo Alto, California
Valar Labs, Palo Alto, California
Valar Labs, Palo Alto, California
Valar Labs, Palo Alto, California
Valar Labs, Palo Alto, California
Department of Urology, Stanford Medicine, Palo Alto, California
Department of Urology, University of Texas Medical Branch, Galveston, Texas
